Wells Fargo & Company Eterna Therapeutics Inc. Commo Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Eterna Therapeutics Inc. Commo stock. As of the latest transaction made, Wells Fargo & Company holds 28 shares of ERNA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 28 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
N/A
2 Added 7.69%
28 $0
Q3 2023

Nov 13, 2023
SELL
N/A
-7 Reduced 21.21%
26 $0
Q2 2023

Aug 15, 2023
BUY
N/A
17 Added 106.25%
33 $0
Q1 2023

May 12, 2023
SELL
N/A
-10 Reduced 38.46%
16 $0
Q4 2022

Feb 13, 2023
BUY
N/A
26 New
26 $0

Others Institutions Holding ERNA

# of Institutions
24
Shares Held
409K
Call Options Held
0
Put Options Held
0
View Full List

About ETERNA THERAPEUTICS INC. COMMO

ERNA Quotes by TradingView
  • Ticker ERNA
More about ERNA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email